A phase II study of plerixafor combined with whole brain radiation therapy (WBRT) for patients with newly diagnosed glioblastoma

被引：0
|
作者：
Cao, Toni
Gu, Yuan
Yagmurlu, Banu
Yerraballa, Hari Priya
Bertrand, Sophie
Naya, Lewis
Miller, Kate
Iv, Michael
Soltys, Scott G.
Patel, Chirag B.
Nagpal, Seema
Thomas, Reena Parada
Brown, Martin
Recht, Lawrence David
机构：
[1] Stanford Univ, Palo Alto, CA 94304 USA
[2] Stanford Canc Inst Palo Alto, Palo Alto, CA USA
[3] Stanford Canc Ctr GI Surg Oncol, Palo Alto, CA USA
[4] Stanford Canc Inst, Stanford, CA USA
[5] Stanford Univ, Stanford, CA 94305 USA
[6] Stanford Canc Ctr GI Surg Oncol, Stanford, CA USA
[7] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[8] Stanford Univ Hosp, Palo Alto, CA USA
[9] Stanford Univ Dept Psychiat & Behav Sci, Palo Alto, CA USA
[10] Stanford Univ Med Ctr, Palo Alto, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2075
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I/II study of dianhydrogalactitol (VAL-083) with radiation therapy in patients with newly diagnosed, MGMT-unmethylated glioblastoma
    Chen, Zhong-ping
    Guo, Chengcheng
    Bacha, Jeffrey
    Langlands, John
    Steino, Anne
    Kwan, Claire
    Kanekal, Sarath
    Schwartz, Richard
    Lopez, Lorena
    Brown, Dennis
    CANCER RESEARCH, 2019, 79 (13)
  • [32] Phase I/II study of dianhydrogalactitol (VAL-083) with radiation therapy in patients with newly diagnosed glioblastoma, MGMT-unmethylated
    Chen, Zhong-ping
    Guo, Chengcheng
    Bacha, Jeffrey
    Steino, Anne
    Langlands, John
    Kwan, Claire
    Kanekal, Sarath
    Schwartz, Richard
    Lopez, Lorena
    Brown, Dennis M.
    CANCER RESEARCH, 2018, 78 (13)
  • [33] Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study
    Navarria, Pierina
    Pessina, Federico
    Tomatis, Stefano
    Soffietti, Riccardo
    Grimaldi, Marco
    Lopci, Egesta
    Chiti, Arturo
    Leonetti, Antonella
    Casarotti, Alessandra
    Rossi, Marco
    Cozzi, Luca
    Ascolese, Anna Maria
    Simonelli, Matteo
    Marcheselli, Simona
    Santoro, Armando
    Clerici, Elena
    Bello, Lorenzo
    Scorsetti, Marta
    ONCOTARGET, 2017, 8 (40) : 67696 - 67708
  • [34] ANLOTINIB COMBINED WITH STUPP REGIMEN IN TREATING PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME: A PHASE II PILOT STUDY
    Lai, Shuzhen
    Chen, Yuanyuan
    NEURO-ONCOLOGY, 2020, 22 : 52 - 52
  • [35] Radiation Dose to the Parotid Glands in Patients Receiving Whole Brain Radiation Therapy (WBRT)
    Rashtian, A.
    Zhang, Y. R.
    Zhuang, A. H.
    Liu, B.
    Ha, J. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S648 - S648
  • [36] PHASE I/II TRIAL OF RADIATION THERAPY, TEMOZOLOMIDE AND PEMBROLIZUMAB FOLLOWED BY TEMOZOLOMIDE AND PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Dixit, Karan
    Kumthekar, Priya
    Kruser, Timothy
    Bloch, Orin
    Chandler, James
    Tate, Matthew
    Raizer, Jeffrey
    NEURO-ONCOLOGY, 2016, 18 : 19 - 19
  • [37] Phase II trial of erlotinib with temozolomide and concurrent radiation therapy in patients with newly diagnosed glioblastoma multiforme: Final results
    Peereboom, D. M.
    Brewer, C. J.
    Sub, J. H.
    Stevens, G. H.
    Barnett, G. H.
    Toms, S. A.
    Elson, P.
    Vogelbaum, M. A.
    Weil, R. J.
    NEURO-ONCOLOGY, 2006, 8 (04) : 448 - 448
  • [38] Phase II trial of erlotinib with temozolomide and concurrent radiation therapy in patients with newly-diagnosed glioblastoma multiforme.
    Brewer, CJ
    Suh, JH
    Stevens, GHJ
    Barnett, GH
    Toms, S
    Vogelbaum, MA
    Weil, R
    Peereboom, DM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 130S - 130S
  • [39] A phase II trial of bevacizumab in patients with recurrent solid tumor brain metastases who have failed whole brain radiation therapy (WBRT).
    Kumthekar, Priya
    Dixit, Karan
    Grimm, Sean Aaron
    Lukas, Rimas Vincas
    Schwartz, Margaret A.
    Rademaker, Alfred
    Sharp, Laura
    Nelson, Valerie
    Raizer, Jeffrey J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] PHASE 1 SAFETY AND PHARMACOKINETIC (PK) STUDY OF VELIPARIB IN COMBINATION WITH WHOLE BRAIN RADIATION THERAPY (WBRT) IN PATIENTS (PTS) WITH BRAIN METASTASES
    Mehta, Minesh P.
    Curran, Walter J.
    Wang, Ding
    Wang, Fen
    Kleinberg, Lawrence
    Brade, Anthony
    Mostafa, Nael
    Zhou, Xiangdong
    Qian, Jiang
    Leahy, Terri
    Desai, Bhardwaj
    Giranda, Vincent
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S120 - S120
12345